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5-FU is a unique anticancer agent with two major pharmaco-biochemical actions: of its active metabolites, FUTP is fraudulently incorporated into RNA and impairs the multiple functions of RNA, while FdUMP blocks the catalytic activity of TS by forming a ternary covalent complex with its co-substrate, 5, 10-CH 2 -FH 4 , which inhibits DNA synthesis. Thus 5-FU potentially exerts both RNAand DNA-directed actions against target cells.
One of the factors determining which action 5-FU preferentially exerts on the target cells seems to be their innate biochemical characteristics of 5-FU metabolism. If the resultant intracellular concentration of FUTP or FdUMP is lower than the effective level, 5-FU may exert only one of its dual actions. However, it seems to exert dual actions against the majority of cancer cells, although the efficacy of such actions varies. Another determinant is the length of the exposure time to 5-FU. We have previously developed a method for the kinetic analysis of the cell-killing action of anticancer agents which can classify them into cell cycle phase-nonspecific (type I) drugs and cell cycle phase-specific (type II) drugs. 1, 2) According to this analysis, FUrd and FdUrd showed typical kinetic profiles for type I and II drugs, respectively. 5-FU had a FUrd-like kinetic profile for cell killing action when cells were exposed for a short time and a FdUrd-like profile when they were continuously exposed for a long time. 3, 4) These results suggested that 5-FU exerts RNA-directed action under short exposure conditions and DNA-directed action under long, continuous exposure conditions. The former requires a high 5-FU concentration, while for the latter, a low concentration is sufficient.
In view of the dual actions of 5-FU, which depend on the exposure time, it might be possible to develop a subline which acquires resistance to short/long exposure to 5-FU, but does not show cross-resistance to long/short exposure. Based on this idea, we have established some 5-FU-resistant sublines of human gastro-intestinal cancer cell lines by repeated long-term exposure to 5-FU. However, we failed to obtain a subline of the type we had expected. In the present study, we tried repeated 1-h exposure of human colon cancer HT-29 cells to 5-FU, and established a subline named HT-29/5-FU/S. This subline is resistant to short-term exposure to 5-FU, exhibited no cross-resistance to long-term exposure to 5-FU, and had rather higher sensitivity than its parent cells. were washed twice with phosphate-buffered saline, then treated twice with 2.5 ml of 10% (wt/vol.) perchloric acid, and RNA was extracted by shaking the precipitated residue in 5 ml of 1 N perchloric acid for 18 h at 4°C. After centrifugation, the supernatant was transferred to a tube, to which another 5 ml of 1 N perchloric acid washing the residue was added. The radioactivity levels in aliquots of the RNA extract were measured using a Beckman model LS 7500 scintillation counter (Fullerton, CA) and the RNA content was estimated by measuring the UV absorbance at 260 nm. -free phosphate-buffered saline, disrupted in 1 ml of 1% NP-40 in a lysis buffer (10 mM Tris-HCl, 5 mM EDTA, 50 mM NaF and 50 mM NaCl; pH 7.5), and centrifuged at 75,000g for 20 min at 4°C in a Beckman model TL-100 ultracentrifuge (Palo Alto, CA). Cold 6 M trichloroacetic acid was added to 500 µl of the supernatant to produce a final concentration of 0.6 M and the mixture was centrifuged. The supernatant was added to 2 vol. of cold Freon containing 17.7% tri-n-octylamine, and the mixture was vortexed and centrifuged. The last procedure was repeated until the pH of the aqueous phase became 7, when this phase was separated and filtered through Ultrafree C3HV. The filtrate was analyzed using a Shimadzu model LC-10A HPLC (Tokyo) equipped with an Inertsil ODS column (250×6.0 mm, 4-mm particle size; GL Sciences, Tokyo). The elution proceeded as described previously.
MATERIALS AND METHODS

Chemicals
Assay for intracellular active metabolites of 5-FU
6) The radioactivity of fractions containing FUTP or FdUMP was measured. Assay of 5-FU-anabolizing enzymes The activities of uridine/thymidine phosphorylase and kinase and OPRT were measured as described by Peters et al. 7) Briefly, phosphorylase was assayed using 0. 5 3 H]5-FU, 2 mM PRPP, 5 mM MgCl 2 , 15 mM 2-glycerophosphate, 0.6 mM α,β-methyleneadenosine diphosphate and 50 mM Tris-HCl (pH 8.0). These mixtures were incubated at 37°C with 40-50 µl of the cytosol in a total volume of 100 µl for 20 min, and the reaction was stopped by heating at 90-100°C. After centrifugation at 14,000 rpm for 2 min in a Tomy model MR-150 centrifuge (Tokyo), 20 µl of the supernatant was charged with the cold carrier on a PEI-cellulose thin-layer chromatography sheet and developed with water. The spots of substrate and product were distinguished under UV and excised, and the level of radioactivity in each was measured. In situ TS assay The in situ TS activity was measured as described previously. 8) Cells (8×10 6 cells/ml) were incubated with or without 5-FU for 5 h at 37°C. H]dUrd (final 37 kBq/ml) was added 2 h after the start of the incubation. The reaction was terminated by transferring 100-µl aliquots into centrifuge tubes containing 200 µl of a 10% activated charcoal suspension in 4% aqueous trichloroacetic acid. The tubes were vigorously stirred by vortexing, then centrifuged at 14,000 rpm for 2 min in a Kubota model KM-15200 microfuge (Tokyo). The radioactivity in 150 µl of the supernatant was determined in a scintillation counter.
RESULTS
Sensitivity to 5-FU and FdUrd
When cells were exposed to various concentrations of 5-FU for 1 h and cultured without the drug for 96 h, the IC 50 values of 5-FU for HT-29 and HT-29/5-FU/S were 0.1 and 0.77 mM, respectively (Fig. 1A) , which indicated 8-fold resistance. However, when cells were continuously exposed to 5-FU for 96 h, the IC 50 values of 5-FU for HT-29 and HT-29/5-FU/S were 0.14 and 0.033 µM, respectively. These results sdemonstrate that HT-29/5-FU/S was resistant to short-term exposure, but became more sensitive to longterm exposure to 5-FU (Fig. 1B) . HT-29/5-FU/S also showed significant collateral sensitivity to FdUrd (Fig.  1C) . 
5-FU incorporation into RNA
Activities of 5-FU-anabolizing enzymes
The activities of five enzymes involved in 5-FU anabolism were measured (Table II) . Only OPRT showed lower activity in HT-29/5-FU/S cells. Uridine phosphorylase/kinase and thymidine phosphorylase exhibited rather higher activity in the resistant cells. There was no significant difference in thymidine kinase activity between the two cell lines. In situ TS activity and its sensitivity to 5-FU Cells were incubated with or without 5-FU for 5 h and the in situ TS activity was determined for the last 3 h (Fig. 3) . 
DISCUSSION
We have established two sublines of human stomach 9) and colon (Inaba et al., unpublished data) cancer cell lines with acquired resistance to long-term exposure to 5-FU. Both of them also showed resistance to short-term exposure to 5-FU. The major mechanism of resistance in these sublines was the decreased production of two active metabolites, FUTP and FdUMP. In the present study, we established a subline of human colon cancer HT-29 cells by repeated 1-h exposure to stepwise-increasing concentrations of 5-FU. This subline manifested 8-fold resistance to 5-FU in a 1-h exposure assay. In contrast, it showed rather higher sensitivity to 5-FU and FdUrd under a 96-h exposure condition (Fig. 1) . Aschele et al. also established 5-FU-resistant sublines of human colon cancer (HCT-8) using two different exposure schedules. 10) One subline developed by repeated 4-h exposure to 5-FU showed 3-fold resistance to short-term exposure to 5-FU but retained full sensitivity to long-term exposure. Decreased incorporation of 5-FU into cellular RNA was found in this cell line. Another subline developed after repeated 7-day exposure to 5-FU exhibited 10-fold increased resistance to long-term exposure and marked cross-resistance to short-term exposure to 5-FU.
11)
Decreased expression of folypolyglutamate synthetase was reported as a novel mechanism of resistance to 5-FU in this cell line. 12) We studied the mechanism of resistance to short-term exposure and the increased sensitivity to long-term exposure to 5-FU in HT-29/5-FU/S cells. A significant reduction of 5-FU incorporation into cellular RNA was observed in HT-29/5-FU/S cells, and this may account for the resistance to 1-h exposure to 5-FU, in view of our previous kinetic analysis of the cell-killing action of 5-FU. In accordance with this, significantly reduced production of FUTP was observed (Table I) . However, a comparative study of pyrimidine enzymes involved in 5-FU activation for the two cell lines did not reveal the cause of the decrease of FUTP. OPRT activity was significantly lower, but the activity of uridine phosphorylase/kinase was rather higher in HT-29/5-FU/S than in HT-29 cells. If the latter pathway is not effective because of a deficiency in the ribose-1-phosphate pool, the decreased activity of OPRT may contribute to the decreased production of FUTP.
An increased level of TS as a target enzyme of 5-FU can be a mechanism of resistance to 5-FU. Copur et al. reported elevated levels of TS protein and m-RNA and amplification of the TS gene in human colon H630 cells which acquired resistance to continuous exposure to 5-FU. 13 ) Therefore, we determined the basal level of in situ TS activity and the inhibitory effect of 5-FU. The basal activity of the in situ TS in HT-29/5-FU/S cells was significantly lower than that in HT-29 cells. Probably as a result of the lower TS activity, the inhibitory effect of 5-FU on in situ TS was more potent in HT-29/5-FU/S than in HT-29 cells (Fig. 3) . This could explain the increased sensitivity of HT-29/5-FU/S cells to long-term exposure to 5-FU, in which DNA-directed action through TS inhibition seems to be predominant. The difference in the effective concentrations of 5-FU (see Figs. 1 and 3 ) might be caused by the difference in exposure time between these two experiments.
In conclusion, an HT-29 subline that had acquired 8-fold increased resistance to short-term exposure to 5-FU showed collateral sensitivity to the same drug under a long-term exposure condition. This result provides additional evidence for the hypothesis that 5-FU exerts different modes of cytotoxic action depending on the exposure time and treatment schedule. 
